Aspirin and reduced risk for cancer metastasis
Can Aspirin Reduce Risk for Cancer Metastasis?
BY Megan Maisel
March 21, 2012
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on March 21, 2012
Results from a report released today in a leading medical journal indicate that low dose daily aspirin reduces the risk of metastasis of several cancers. According to articles in The Lancet, the protective effect occurs within 3-5 years of beginning aspirin use.
Read more about the study in a post from our Cancer Frontline blog.
Raymond DuBois, M.D., Ph.D, MD Anderson's provost and executive vice president and a professor of cancer biology and cancer medicine, shares his insights on the study's significance and addresses questions about aspirin dose, and how cancer patients should respond to this news.